348 related articles for article (PubMed ID: 24924222)
1. Deletion of astroglial CXCL10 delays clinical onset but does not affect progressive axon loss in a murine autoimmune multiple sclerosis model.
Mills Ko E; Ma JH; Guo F; Miers L; Lee E; Bannerman P; Burns T; Ko D; Sohn J; Soulika AM; Pleasure D
J Neuroinflammation; 2014 Jun; 11():105. PubMed ID: 24924222
[TBL] [Abstract][Full Text] [Related]
2. Conditional ablation of astroglial CCL2 suppresses CNS accumulation of M1 macrophages and preserves axons in mice with MOG peptide EAE.
Moreno M; Bannerman P; Ma J; Guo F; Miers L; Soulika AM; Pleasure D
J Neurosci; 2014 Jun; 34(24):8175-85. PubMed ID: 24920622
[TBL] [Abstract][Full Text] [Related]
3. Systemic administration of orexin A ameliorates established experimental autoimmune encephalomyelitis by diminishing neuroinflammation.
Becquet L; Abad C; Leclercq M; Miel C; Jean L; Riou G; Couvineau A; Boyer O; Tan YV
J Neuroinflammation; 2019 Mar; 16(1):64. PubMed ID: 30894198
[TBL] [Abstract][Full Text] [Related]
4. PI3Kγ inhibition alleviates symptoms and increases axon number in experimental autoimmune encephalomyelitis mice.
Li H; Park D; Abdul-Muneer PM; Xu B; Wang H; Xing B; Wu D; Li S
Neuroscience; 2013 Dec; 253():89-99. PubMed ID: 24012746
[TBL] [Abstract][Full Text] [Related]
5. IFN-inducible protein 10/CXC chemokine ligand 10-independent induction of experimental autoimmune encephalomyelitis.
Klein RS; Izikson L; Means T; Gibson HD; Lin E; Sobel RA; Weiner HL; Luster AD
J Immunol; 2004 Jan; 172(1):550-9. PubMed ID: 14688366
[TBL] [Abstract][Full Text] [Related]
6. Sustained TNF production by central nervous system infiltrating macrophages promotes progressive autoimmune encephalomyelitis.
Valentin-Torres A; Savarin C; Hinton DR; Phares TW; Bergmann CC; Stohlman SA
J Neuroinflammation; 2016 Feb; 13():46. PubMed ID: 26906225
[TBL] [Abstract][Full Text] [Related]
7. Bone morphogenetic proteins 4, 6, and 7 are up-regulated in mouse spinal cord during experimental autoimmune encephalomyelitis.
Ara J; See J; Mamontov P; Hahn A; Bannerman P; Pleasure D; Grinspan JB
J Neurosci Res; 2008 Jan; 86(1):125-35. PubMed ID: 17722066
[TBL] [Abstract][Full Text] [Related]
8. VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage.
Abad C; Jayaram B; Becquet L; Wang Y; O'Dorisio MS; Waschek JA; Tan YV
J Neuroinflammation; 2016 Jun; 13(1):169. PubMed ID: 27357191
[TBL] [Abstract][Full Text] [Related]
9. Expression of iron homeostasis proteins in the spinal cord in experimental autoimmune encephalomyelitis and their implications for iron accumulation.
Zarruk JG; Berard JL; Passos dos Santos R; Kroner A; Lee J; Arosio P; David S
Neurobiol Dis; 2015 Sep; 81():93-107. PubMed ID: 25724358
[TBL] [Abstract][Full Text] [Related]
10. Brain gray matter astroglia-specific connexin 43 ablation attenuates spinal cord inflammatory demyelination.
Une H; Yamasaki R; Nagata S; Yamaguchi H; Nakamuta Y; Indiasari UC; Cui Y; Shinoda K; Masaki K; Götz M; Kira JI
J Neuroinflammation; 2021 Jun; 18(1):126. PubMed ID: 34090477
[TBL] [Abstract][Full Text] [Related]
11. Erythropoietin reduces experimental autoimmune encephalomyelitis severity via neuroprotective mechanisms.
Moransard M; Bednar M; Frei K; Gassmann M; Ogunshola OO
J Neuroinflammation; 2017 Oct; 14(1):202. PubMed ID: 29029628
[TBL] [Abstract][Full Text] [Related]
12. Microglia response in retina and optic nerve in chronic experimental autoimmune encephalomyelitis.
Horstmann L; Kuehn S; Pedreiturria X; Haak K; Pfarrer C; Dick HB; Kleiter I; Joachim SC
J Neuroimmunol; 2016 Sep; 298():32-41. PubMed ID: 27609273
[TBL] [Abstract][Full Text] [Related]
13. Paricalcitol improves experimental autoimmune encephalomyelitis (EAE) by suppressing inflammation via NF-κB signaling.
Zhang D; Qiao L; Fu T
Biomed Pharmacother; 2020 May; 125():109528. PubMed ID: 32106388
[TBL] [Abstract][Full Text] [Related]
14. Rescue from acute neuroinflammation by pharmacological chemokine-mediated deviation of leukocytes.
Berghmans N; Heremans H; Li S; Martens E; Matthys P; Sorokin L; Van Damme J; Opdenakker G
J Neuroinflammation; 2012 Oct; 9():243. PubMed ID: 23095573
[TBL] [Abstract][Full Text] [Related]
15. Role of glial 14-3-3 gamma protein in autoimmune demyelination.
Lee DH; Steinacker P; Seubert S; Turnescu T; Melms A; Manzel A; Otto M; Linker RA
J Neuroinflammation; 2015 Oct; 12():187. PubMed ID: 26438180
[TBL] [Abstract][Full Text] [Related]
16. Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.
Prinz J; Karacivi A; Stormanns ER; Recks MS; Kuerten S
PLoS One; 2015; 10(12):e0144847. PubMed ID: 26658811
[TBL] [Abstract][Full Text] [Related]
17. Severe disease, unaltered leukocyte migration, and reduced IFN-gamma production in CXCR3-/- mice with experimental autoimmune encephalomyelitis.
Liu L; Huang D; Matsui M; He TT; Hu T; Demartino J; Lu B; Gerard C; Ransohoff RM
J Immunol; 2006 Apr; 176(7):4399-409. PubMed ID: 16547278
[TBL] [Abstract][Full Text] [Related]
18. Laquinimod protects the optic nerve and retina in an experimental autoimmune encephalomyelitis model.
Wilmes AT; Reinehr S; Kühn S; Pedreiturria X; Petrikowski L; Faissner S; Ayzenberg I; Stute G; Gold R; Dick HB; Kleiter I; Joachim SC
J Neuroinflammation; 2018 Jun; 15(1):183. PubMed ID: 29903027
[TBL] [Abstract][Full Text] [Related]
19. Astrocytes play a key role in EAE pathophysiology by orchestrating in the CNS the inflammatory response of resident and peripheral immune cells and by suppressing remyelination.
Brambilla R; Morton PD; Ashbaugh JJ; Karmally S; Lambertsen KL; Bethea JR
Glia; 2014 Mar; 62(3):452-67. PubMed ID: 24357067
[TBL] [Abstract][Full Text] [Related]
20. Regulatory role of oligodendrocyte gap junctions in inflammatory demyelination.
Papaneophytou CP; Georgiou E; Karaiskos C; Sargiannidou I; Markoullis K; Freidin MM; Abrams CK; Kleopa KA
Glia; 2018 Dec; 66(12):2589-2603. PubMed ID: 30325069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
